ALK and lymphoma: Further investigation of our whole lymphoma cohort with this newly developed ELISA technique will distinguish whether this higher frequency can be explained by the different methodology used or instead reflects a higher immunogenicity of ALK-positive ALCL compared to NSCLC, possibly because ALK expression in ALCL cells is typically higher than in NSCLC cells [19].